A study on patients with gastric cancer who underwent neoadjuvant chemotherapy showed that high AKR1B10 expression was associated with lymph node metastasis and a poor response to neoadjuvant chemotherapy [79]. The gene discussed is AKR1B10; the disease is metastatic malignant neoplasm in the lymph nodes.